Annals of the Rheumatic Diseases: 79 (5)

Editorial

COVID-19 and rheumatology: first steps towards a different future? (15 April, 2020) Free
Iain B McInnes

Viewpoint

Disruptive innovation in rheumatology: new networks of global public–private partnerships are needed to take advantage of scientific progress (5 March, 2020)
Tom WJ Huizinga, V Michael Holers, Jennifer Anolik, Michael B Brenner, Christopher Dominic Buckley, Vivian Bykerk, Sean E Connolly, Kevin D Deane, Jianping Guo, Martin Hodge, Steve Hoffmann, Frank Nestle, Costantino Pitzalis, Soumya Raychaudhuri, Kazuhiko Yamamoto, Zhanguo Li, Lars Klareskog

Rheumatoid arthritis

Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial (2 April, 2020)
Sofia Pazmino, Annelies Boonen, Veerle Stouten, Diederik De Cock, Johan Joly, Kristien Van der Elst, Rene Westhovens, Patrick Verschueren
Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden (11 March, 2020)
Tine Iskov Kopp, Bénédicte Delcoigne, Elizabeth V Arkema, Rikke Kart Jacobsen, Melinda Magyari, Else Helene Ibfelt, Henning Locht, Finn Sellebjerg, Rene Lindholm Cordtz, Dorte V Jensen, Johan Askling, Lene Dreyer
Immunosuppression and the risk of readmission and mortality in patients with rheumatoid arthritis undergoing hip fracture, abdominopelvic and cardiac surgery (24 March, 2020)
Michael D George, Joshua F Baker, Kevin L Winthrop, Seth D Goldstein, E Alemao, Lang Chen, Qufei Wu, Fenglong Xie, Jeffrey R Curtis
Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors (11 March, 2020)
Hjalmar Wadström, Andreas Pettersson, Karin E Smedby, Johan Askling
Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease (10 March, 2020)
Raul Castellanos-Moreira, Sebastian Cruz Rodríguez-García, Maria Jose Gomara, Virginia Ruiz-Esquide, Andrea Cuervo, Ivette Casafont-Solé, Julio Ramírez, Susana Holgado, Jose A Gómez-Puerta, Juan D Cañete, Isabel Haro, Raimon Sanmarti

Spondyloarthritis

Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study (6 April, 2020)
Désirée van der Heijde, Lianne S Gensler, Atul Deodhar, Xenofon Baraliakos, Denis Poddubnyy, Alan Kivitz, Mary Katherine Farmer, Dominique Baeten, Nadine Goldammer, Jason Coarse, Marga Oortgiesen, Maxime Dougados
Reactive arthritis and other musculoskeletal symptoms associated with acquisition of diarrhoeagenic Escherichia coli (DEC)
(16 March, 2020)
Riitta Tuompo, Tinja Lääveri, Timo Hannu, Sari H Pakkanen, Juha Kirveskari, Marjatta Leirisalo-Repo, Anu Kantele

Systemic lupus erythematosus

Impact of the new American College of Cardiology/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus (10 March, 2020) Free
Konstantinos Tselios, Dafna D Gladman, Jiandong Su, Murray Urowitz

Systemic sclerosis

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial (15 April, 2020)
Dinesh Khanna, Yannick Allanore, Christopher P Denton, Masataka Kuwana, Marco Matucci-Cerinic, Janet E Pope, Tatsuya Atsumi, Radim Bečvář, László Czirják, Eric Hachulla, Tomonori Ishii, Osamu Ishikawa, Sindhu R Johnson, Ellen De Langhe, Chiara Stagnaro, Valeria Riccieri, Elena Schiopu, Richard M Silver, Vanessa Smith, Virginia Steen, Wendy Stevens, Gabriella Szücs, Marie-Elise Truchetet, Melanie Wosnitza, Kaisa Laapas, Janethe de Oliveira Pena, Zhen Yao, Frank Kramer, Oliver Distler
Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis (11 March, 2020)
Masataka Kuwana, Christiana Blair, Tomohiko Takahashi, Jonathan Langley, John G Coghlan

Osteoarthritis

Metformin limits osteoarthritis development and progression through activation of AMPK signalling (10 March, 2020)
Jun Li, Bin Zhang, Wei-Xiao Liu, Ke Lu, Haobo Pan, Tingyu Wang, Chun-do Oh, Dan Yi, Jian Huang, Lan Zhao, Guangzhi Ning, Cong Xing, Guozhi Xiao, Ru Liu-Bryan, Shiqing Feng, Di Chen
Faecal microbiota transplantation from metabolically compromised human donors accelerates osteoarthritis in mice (23 March, 2020)
ZeYu Huang, Jing Chen, BoLei Li, Benhua Zeng, Ching-Heng Chou, Xin Zheng, JingWei Xie, Hao Li, Yu Hao, Guo Chen, FuXing Pei, Bin Shen, Virginia B Kraus, Hong Wei, Xuedong Zhou, Lei Cheng

Crystal arthropathies

Subtype-specific gout susceptibility loci and enrichment of selection pressure on ABCG2 and ALDH2 identified by subtype genome-wide meta-analyses of clinically defined gout patients
(1 April, 2020)
Akiyoshi Nakayama, Masahiro Nakatochi, Yusuke Kawamura, Ken Yamamoto, Hirofumi Nakaoka, Seiko Shimizu, Toshihide Higashino, Teruhide Koyama, Asahi Hishida, Kiyonori Kuriki, Miki Watanabe, Toru Shimizu, Keiko Ooyama, Hiroshi Ooyama, Mitsuo Nagase, Yuji Hidaka, Daisuke Matsui, Takashi Tamura, Takeshi Nishiyama, Chisato Shimanoe, Sakurako Katsuura-Kamano, Naoyuki Takashima, Yuya Shirai, Makoto Kawaguchi, Mikiya Takao, Ryo Sugiyama, Yuzo Takada, Takahiro Nakamura, Hiroshi Nakashima, Masashi Tsunoda, Inaho Danjoh, Atsushi Hozawa, Kazuyoshi Hosomichi, Yu Toyoda, Yu Kubota, Tappei Takada, Hiroshi Suzuki, Blanka Stiburkova, Tanya J. Major, Tony R. Merriman, Nagato Kuriyama, Haruo Mikami, Toshiro Takezaki, Keitaro Matsuo, Sadao Suzuki, Tatsuo Hosoya, Yoichiro Kamatani, Michiaki Kubo, Kimiyoshi Ichida, Kenji Wakai, Ituro Inoue, Yukinori Okada, Nariyoshi Shinomiya, Hirotaka Matsuo

Letters

To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic (2 April, 2020)
Francesca Romana Spinelli, Fulvia Ceccarelli, Manuela Di Franco, Fabrizio Conti
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies (2 April, 2020)
Sara Monti, Silvia Balduzzi, Paolo Delvino, Elisa Bellis, Verdiana Serena Quadrelli, Carlomaurizio Montecucco
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD (2 April, 2020)
Carina Mihai, Rucsandra Dobrota, Maria Schröder, Alexandru Garaiman, Suzana Jordan, Mike Oliver Becker, Britta Maurer, Oliver Distler
Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib (11 March, 2020)
Kevin L Winthrop, Ann Wouters, Ernest H Choy, Connie Chen, Pinaki Biswas, Lisy Wang, Koshika Soma, Elie Needle, Hernan Valdez, William FC Rigby
CDAI and DAS28 in the management of rheumatoid arthritis in clinical practice (29 January, 2020)
Satoshi Takanashi, Yuko Kaneko, Tsutomu Takeuchi
Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus (3 January, 2020)
Keisuke Maeshima, Hirotaka Shibata
Histopathological subgrouping versus renal risk score for the prediction of end-stage renal disease in ANCA-associated vasculitis (10 February, 2020)
Onay Gercik, Emre Bilgin, Dilek Solmaz, Fulya Cakalagaoglu, Arzu Saglam, Ozge Aybi, Riza Can Kardas, Zeki Soypacaci, Gokhan Kabadayi, Tolga Yildirim, Idil Kurut Aysin, Omer Karadag, Servet Akar

Electronic pages

Inflammatory and non-inflammatory triggers of acute coronary syndromes (6 March, 2019) Free
Mehmet Eyuboglu
Response to: ‘Inflammatory and non-inflammatory triggers of acute coronary syndromes’ by Eyuboglu (28 March, 2019) Free
Helga Westerlind, Marie Holmqvist, Lotta Ljung, Thomas Frisell, Johan Askling
Assessment of responsiveness of the musculoskeletal component of SLE-DAS in an independent cohort (25 April, 2019) Free
Sabih-Ul Hassan, Khaled Mahmoud, Edward M Vital
Response to: ‘Assessment of responsiveness of the musculoskeletal component of SLE-DAS in an independent cohort’, by Hassan et al
(25 April, 2019) Free
Diogo Jesus, Margherita Zen, Andrea Doria, Luís Sousa Inês
Adipose stromal vascular fraction and regenerative therapy in SSc: response to the article by Magalon et al
(2 February, 2019) Free
Paola Di Benedetto, Paola Cipriani, Piero Ruscitti, Vasiliki Liakouli, Roberto Giacomelli
Response to: ‘Adipose stromal vascular fraction and regenerative therapy in SSc: response to the article by Magalon et al’ by De Benedetto et al
(20 February, 2019) Free
Jérémy Magalon, Mélanie Velier, Stéphanie Simoncini, Françoise Dignat-George, Brigitte Granel, Pascale Paul, Florence Sabatier
Could autologous adipose-derived stromal vascular fraction turn out an unwanted source of profibrotic myofibroblasts in systemic sclerosis? (13 March, 2019) Free
Mirko Manetti
Response to: ‘Could autologous adipose-derived stromal vascular fraction turn out an unwanted source of profibrotic myofibroblasts in systemic sclerosis?’ by Manetti (9 April, 2019) Free
Melanie Velier, Jeremy Magalon, Stephanie Simoncini, Françoise Dignat-George, Brigitte Granel, Pascale Paul, Florence Sabatier
MYCYC: unravelling the long road ahead in ANCA-associated vasculitis (20 March, 2019) Free
Siddharth Jain, Arghya Chattopadhyay, Shankar Naidu, Aman Sharma
Response to: ‘MYCYC, unravelling the long road ahead in ANCA-associated vasculitis’ by Jain et al
(20 March, 2019) Free
Lorraine Harper, Rachel B Jones
Changing landscape of immunosuppression in ANCA-associated vasculitis (12 February, 2019) Free
Sergey V Moiseev, Ilya Smitienko, Nikolai Bulanov, Ekaterina Karovaikina, Pavel I Novikov

Main menu

Table of contents

May 2020 - Volume 79 - 5

Editorial

Viewpoint

Rheumatoid arthritis

Spondyloarthritis

Systemic lupus erythematosus

Systemic sclerosis

Osteoarthritis

Crystal arthropathies

Letters

Electronic pages

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

May 2020 - Volume 79 - 5

Editorial

Viewpoint

Rheumatoid arthritis

Spondyloarthritis

Systemic lupus erythematosus

Systemic sclerosis

Osteoarthritis

Crystal arthropathies

Letters

Electronic pages

Issue Information